3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Multiple Myeloma
15
Myelodysplastic Syndromes
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Hematologic Neoplasms
5
Myeloproliferative Disorders
4
Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Neuroblastoma
3
Neoplasm, Residual
3
Leukemia, Myelomonocytic, Juvenile
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Precancerous Conditions
2
Neoplasms, Plasma Cell
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Interventions
Bevacizumab
37
Paclitaxel
33
Carboplatin
25
pembrolizumab
23
Specimen Handling
21
olaparib
19
Magnetic Resonance Spectroscopy
19
Gemcitabine
18
liposomal doxorubicin
16
Cyclophosphamide
16
fludarabine
12
Topotecan
12
Biopsy
12
niraparib
11
Cisplatin
10
Fulvestrant
9
Taxes
8
Nivolumab
8
Immunoglobulin G
8
Disulfides
8
Doxorubicin
7
palbociclib
6
aldesleukin
6
Surveys and Questionnaires
6
Oxaliplatin
5
Letrozole
5
Fluorouracil
5
trastuzumab deruxtecan
4
oregovomab
4
mirvetuximab soravtansine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Melphalan
×
90 days
×
Clear all
No trials found.